← Leaderboards
Jorge Luis Sanchez
Asociacion Civil Impacta Salud Y Educacn
$34,713,744
Attributed
$50,879,660
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$53,917,894 · 6
By mechanism
UM1$39,497,255 · 1
U01$11,124,906 · 1
U19$3,138,408 · 2
R03$107,645 · 1
D43$49,680 · 1
Top collaborators
- Alberto La Rosa9 shared
- Javier R Lama6 shared
Most similar at Asociacion Civil Impacta Salud Y Educacn
Same institution · by research overlap
- Javier R Lama$8,412,654
- Alberto La Rosa$7,753,263
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsAids Clinical Trial GroupClinical Research SiteResearch PersonnelPeruClinical Trials UnitHiv Vaccine Trials NetworkPreventionUnited States National Institutes Of HealthClinical TrialsAreaAids PreventionHiv Prevention Trials NetworkSafetyMen Who Have Sex With MenPreventProtocols DocumentationHiv VaccineCountryFutureGrantAnti-Retroviral AgentsClinical ResearchIncidence
Grant awards (32)
PERU Clinical Trial Unit$2,328,404
UM1 · FY2025 · AI · contact PI
PERU Clinical Trial Unit$235,946
UM1 · FY2025 · AI · contact PI
PERU Clinical Trial Unit$142,830
UM1 · FY2025 · AI · contact PI
PERU Clinical Trial Unit$142,830
UM1 · FY2025 · AI · contact PI
PERU Clinical Trial Unit$2,202,177
UM1 · FY2024 · AI · contact PI
PERU Clinical Trial Unit$165,844
UM1 · FY2024 · AI · contact PI
PERU Clinical Trial Unit$2,365,819
UM1 · FY2023 · AI · contact PI
PERU Clinical Trial Unit$3,855,616
UM1 · FY2022 · AI · contact PI
PERU Clinical Trial Unit$4,067,059
UM1 · FY2021 · AI · contact PI
IMPACTA PERU CLINICAL TRIALS UNIT$4,328,745
UM1 · FY2020 · AI
IMPACTA PERU CLINICAL TRIALS UNIT$5,080,925
UM1 · FY2019 · AI
IMPACTA PERU CLINICAL TRIALS UNIT$1,693,877
UM1 · FY2018 · AI
IMPACTA PERU CLINICAL TRIALS UNIT$1,691,063
UM1 · FY2017 · AI
IMPACTA PERU CLINICAL TRIALS UNIT$1,984,088
UM1 · FY2016 · AI · contact PI
IMPACTA PERU CLINICAL TRIALS UNIT$2,046,610
UM1 · FY2015 · AI · contact PI
IMPACTA PERU CLINICAL TRIALS UNIT$2,354,219
UM1 · FY2014 · AI · contact PI
THE IMPACTA PERU CLINICAL TRIALS UNIT$2,434,595
UM1 · FY2013 · AI · contact PI
THE IMPACTA PERU CLINICAL TRIALS UNIT$2,376,608
UM1 · FY2012 · AI · contact PI
THE IMPACTA PERU CLINICAL TRIALS UNIT$2,280,954
U01 · FY2011 · AI · contact PI
THE IMPACTA PERU CLINICAL TRIALS UNIT$2,037,651
U01 · FY2010 · AI · contact PI
THE IMPACTA PERU CLINICAL TRIALS UNIT$63,402
U01 · FY2010 · AI · contact PI
A Step Forward for a Latin American AIDS Research and Training Program (LAARTP)$24,840
D43 · FY2010 · TW · contact PI
THE IMPACTA PERU CLINICAL TRIALS UNIT$2,000,073
U01 · FY2009 · AI · contact PI
A Step Forward for a Latin American AIDS Research and Training Program (LAARTP)$24,840
D43 · FY2009 · TW · contact PI
THE IMPACTA PERU CLINICAL TRIALS UNIT$2,165,121
U01 · FY2008 · AI · contact PI
THE IMPACTA PERU CLINICAL TRIALS UNIT$2,577,705
U01 · FY2007 · AI · contact PI
HIV pathogenesis, prevention and treatment in the Andes$1,011,257
U19 · FY2006 · AI · contact PI
Administration and Community Education$100,174
U19 · FY2006 · AI · contact PI
HIV pathogenesis, prevention and treatment in the Andes$1,026,977
U19 · FY2005 · AI
HIV pathogenesis, prevention and treatment in the Andes$1,000,000
U19 · FY2004 · AI
HIV Pathogenesis, prevention and treatment in the Andes$53,925
R03 · FY2002 · AI
HIV Pathogenesis, prevention and treatment in the Andes$53,720
R03 · FY2001 · AI